Skip to content

Long-term clinical follow-up in post-acute infectious syndrome

Long-term clinical follow-up in post-acute infectious syndrome - PAIS-Follow-Up

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
DRKS
Registry ID
DRKS00035965
Enrollment
500
Registered
2025-01-21
Start date
2024-12-02
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

G93.3

Interventions

Group 1: This is a cohort study: a registry will be set up to enrol consecutive patients after acute COVID-19 disease or other infections who have persistent symptoms in the sense of a post-acute infe

Sponsors

Universitätsklinikum Heidelberg, Abteilung Allgemeinmedizin und Versorgungsforschung
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: The prospective analysis from the date of approval will include all consenting patients who have had SARS-CoV-2 infection or any other infection consistent with the symptoms leading to presentation and who give written consent to be included in the study.

Exclusion criteria

Exclusion criteria: Lack of legal capacity, lack of consent, execution of sentence, patients < 18 years of age.

Design outcomes

Primary

MeasureTime frame
To establish a registry in which patients with persistent symptoms of post-acute infection syndrome after acute COVID-19 disease or other infections will be consecutively enrolled. The primary objective of the study is to characterize patients with regard to the long-term consequences of the post-acute infection syndrome by recording patient self-assessments using questionnaires and clinical and laboratory parameters.

Secondary

MeasureTime frame
Follow-up of patients as part of medically indicated follow-up examinations (either as part of re-admissions) or as part of written follow-up surveys to record the course of the disease, (experience of) use, factors influencing the course of the disease and the development of long-term sequelae.

Countries

Germany

Contacts

Public ContactSandra Stengel

Universitätsklinikum Heidelberg, Abteilung Allgemeinmedizin und Versorgungsforschung

sandra.stengel@med.uni-heidelberg.de+49 6221 5632606

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Aug 10, 2026